Mary Disis
Dr. Disis is the Helen B. Slonaker Endowed Professor for Cancer Research at the University of Washington (UW), Associate Dean for Translational Health Sciences in the UW School of Medicine, Professor of Medicine and Adjunct Professor of Pathology and Obstetrics and Gynecology at UW and a Member of the Fred Hutchinson Cancer Center. She is the Director of UW Medicine’s Cancer Vaccine Institute and the Institute for Translational Health Science (ITHS). Her research interest is in the discovery of new immunologic targets in solid tumors for the development of vaccine and cellular therapy for the treatment and prevention of common malignancies. In addition, her group evaluates the use of the immune system to aid in the diagnosis of cancer and develops novel assays and approaches to quantitate and characterize human immunity. She holds several patents in the field of targeted cancer immunotherapy and immune-based diagnostics. Dr. Disis is a member of the American Society of Clinical Investigation, the Association of American Physicians, and is an elected member of Sigma Xi Scientific Honor Society. She is an American Cancer Society Clinical Professor, Deputy Editor, JAMA, and the Editor-in-Chief of JAMA Oncology.
Financial relationships
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:Bavarian NordicTopic:VaccinesDate added:06/15/2023Date updated:06/15/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:VeannaTopic:Immune therapyDate added:06/15/2023Date updated:06/15/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:PrecigenTopic:VaccinesDate added:06/15/2023Date updated:06/15/2023
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:Aston SciTopic:VaccinesDate added:06/15/2023Date updated:06/15/2023